Using Animal Models for Gender-Affirming Hormone Therapy

被引:3
|
作者
Aghi, Krisha [1 ]
Goetz, Teddy G. [2 ]
Pfau, Daniel R. [3 ,4 ,5 ]
Sun, Simon D. [6 ,7 ]
Guthman, Eartha Mae [7 ,8 ]
Roepke, Troy A. [9 ,10 ]
机构
[1] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA
[2] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[3] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Div Pediat Endocrinol Diabet & Metab, Ann Arbor, MI 48109 USA
[6] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
[7] Ctr Appl Transgender Studies, Chicago, IL USA
[8] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA
[9] Rutgers State Univ, Sch Environm & Biol Sci, Dept Anim Sci, New Brunswick, NJ 08901 USA
[10] Rutgers State Univ, 84 Lipman Dr,Bartlett Hall, New Brunswick, NJ 08901 USA
关键词
gender identity; gender-affirming hormone therapy; steroids; estrogens; testosterone; animal models;
D O I
10.1210/jendso/bvad144
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have recently proposed experimental design guidelines and areas of study for preclinical rodent models of gender-affirming hormone therapy in neuroscience. These guidelines also apply to any field subject to the influences of gonadal steroid hormones, including metabolism and growth, cancer, and physiology. This perspective briefly describes our suggestions for these fields. Studying the effects of exogenous steroid hormones will have translational benefits for the community. We also discuss the need for equitable practices for cisgender scientists who wish to implement these guidelines and engage with the community. It is necessary that community-informed practices are implemented in preclinical research to maximize the benefit to transgender, nonbinary, and/or gender diverse (TNG) healthcare, which is currently in jeopardy in the United States, Europe, and across the globe.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Gender-Affirming Hormone Therapy What the Head and Neck Surgeon Should Know
    Haben, C. Michael
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2022, 55 (04) : 715 - 726
  • [42] Continuation of Gender-Affirming Hormone Therapy in Transgender and Gender-Diverse Individuals: A Systematic Review
    Gupta, Pranav
    Cunha, Luisa Marin
    Diego, Daniela
    Tangpricha, Vin
    ENDOCRINE PRACTICE, 2024, 30 (12) : 1206 - 1211
  • [43] Gynecological Providers' Willingness to Prescribe Gender-Affirming Hormone Therapy for Transgender Patients
    Shires, Deirdre A.
    Prieto, Lucas R.
    Woodford, Michael R.
    Jaffee, Kim D.
    Stroumsa, Daphna
    TRANSGENDER HEALTH, 2022, 7 (04) : 323 - 328
  • [44] New Data to Challenge Gender-affirming Hormone Therapy Prescribing Practice Comment
    Reisman, Tamar
    Safer, Joshua D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (05) : E2365 - E2366
  • [45] Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy
    Konadu, Melisande E.
    Reed, Murray B.
    Kaufmann, Ulrike
    Handschuh, Patricia A.
    Spurny-Dworak, Benjamin
    Kloebl, Manfred
    Schmidt, Clemens
    Godbersen, Godber M.
    Briem, Elisa
    Seiger, Rene
    Baldinger-Melich, Pia
    Kranz, Georg S.
    Lanzenberger, Rupert
    Spies, Marie
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2023, 48 (05): : E369 - E375
  • [46] The Effects of Gender-Affirming Hormone Therapy on Quality of Life: The Importance of Research on Youth
    Mazur, Monika
    Larionow, Pawel
    HEALTHCARE, 2024, 12 (13)
  • [47] Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy
    Silva, Eliane D.
    Fighera, Tayane M.
    Allgayer, Roberta M.
    Lobato, Maria Ines R.
    Spritzer, Poli Mara
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [48] Blood Pressure Effects of Gender-Affirming Hormone Therapy in Transgender and Gender-Diverse Adults
    Banks, Katherine
    Kyinn, Mabel
    Leemaqz, Shalem Y.
    Sarkodie, Eleanor
    Goldstein, Deborah
    Irwig, Michael S.
    HYPERTENSION, 2021, 77 (06) : 2066 - 2074
  • [49] Lipid profiles and hypertriglyceridemia among transgender and gender diverse adults on gender-affirming hormone therapy
    Leemaqz, Shalem Y.
    Kyinn, Mabel
    Banks, Katherine
    Sarkodie, Eleanor
    Goldstein, Deborah
    Irwig, Michael S.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (01) : 103 - 111
  • [50] Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals
    -Rake, Elizabeth J. Cathcart
    Ruddy, Kathryn J.
    Tevaarwerk, Amye J.
    Jatoi, Aminah
    MATURITAS, 2024, 181